These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8908935)

  • 1. Pediatric HIV infection: a primer for pharmacists.
    Cohen LG; Noormohamed SE
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):580-95. PubMed ID: 8908935
    [No Abstract]   [Full Text] [Related]  

  • 2. A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.
    Roca B; Olmos P; Mínguez C; Arnedo A; Usó J; Teruel C; Segarra M; Sáez-Royuela A; Simón E
    Scand J Infect Dis; 1998; 30(4):426-8. PubMed ID: 9817530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of late-state HIV infection.
    Millard PS
    J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for HIV infection.
    Med Lett Drugs Ther; 2000 Jan; 42(1069):1-6. PubMed ID: 10683666
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with HIV-1 RNA below 1000 copies/ml after 48 weeks on dual nucleoside combination therapy. Delta Coordinating Committee.
    Flandre P
    AIDS; 1999 Feb; 13(3):430-1. PubMed ID: 10199241
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for HIV infection.
    Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
    AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-retroviral treatment. Treatment modification: toxicity management].
    Ocaña I; Laguna F; Pulido F; Bascuñana A
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():31-5. PubMed ID: 9053025
    [No Abstract]   [Full Text] [Related]  

  • 10. Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
    Am J Health Syst Pharm; 1998 Jun; 55(11):1106, 1108. PubMed ID: 9626369
    [No Abstract]   [Full Text] [Related]  

  • 11. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of nucleoside analogues in the treatment of HIV-infected children.
    Husson RN; Pizzo PA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1059-64. PubMed ID: 1323984
    [No Abstract]   [Full Text] [Related]  

  • 13. The development of resistance of HIV-1 to zalcitabine.
    Craig C; Moyle G
    AIDS; 1997 Mar; 11(3):271-9. PubMed ID: 9147417
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
    Foli A; Maserati R; Minoli L; Wainberg MA; Gallo RC; Lisziewicz J; Lori F
    AIDS; 1998 Jun; 12(9):1113-4. PubMed ID: 9662215
    [No Abstract]   [Full Text] [Related]  

  • 15. The Delta trial.
    Zaretsky MD
    Lancet; 1997 Feb; 349(9048):358-9. PubMed ID: 9024402
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
    Henry K; Erice A; Tierney C; Balfour HH; Fischl MA; Kmack A; Liou SH; Kenton A; Hirsch MS; Phair J; Martinez A; Kahn JO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):339-49. PubMed ID: 9833742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.
    Albrecht MA; Hughes MD; Liou SH; Katzenstein DA; Murphy R; Balfour HH; Para MF; Valdez H; Hammer SM;
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1337-44. PubMed ID: 11018853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on nevirapine: quest for a niche.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What they say about nucleoside drugs.
    Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.